JP Patent

JP6786486B2 — 多発性硬化症の治療方法

Assigned to Biogen MA Inc · Expires 2020-11-18 · 5y expired

What this patent protects

Patent listed against Tecfidera.

Drugs covered by this patent

Tecfidera (DIMETHYL FUMARATE) · Biogen

Patent Metadata

Patent number: JP6786486B2
Jurisdiction: JP
Classification: —
Expires: 2020-11-18
Drug substance claim: No
Drug product claim: No
Assignee: Biogen MA Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.